Our experience with the serum-transfer model of arthritis did not highlight powerful inhibitory properties of hrAnxA1 on joint inflammation, but 1) a cleavage-resistant AnxA1 was effective in attenuating joint disease, and 2) dexamethasone lost most of its efficacy in AnxA1 null mice (49). This evidence concerns the gene ANXA1 and arthropathy.